Real-time enrollment status for this her2+ cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06324357 |
| Recruiting Status | Recruiting |
| Condition | HER2+ Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 582 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | February 18, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06324357 is currently recruiting participants. This clinical trial study for her2+ cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06324357 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06324357 was last updated 1 week ago (February 18, 2026). HelloStudys verifies this status automatically.